Icahn Enterprises L.P. (IEP) Earnings Call Transcript & Summary

November 3, 2026

NASDAQ US Industrials Industrial Conglomerates earnings 10 min

Earnings Call Speaker Segments

Joseph Passeri

executive
#1

Thanks, operator. Under the Private Securities Litigation Reform Act of 1995, there's a safe harbor for the forward-looking statements in this presentation, and also for statements about how our businesses and potential acquisitions are expected to perform and the plans we have for them. Forward-looking statements can be identified by words such as expects, anticipates, intends, plans, believes, seeks, estimates, will, or similar expressions, and they cover — though aren't limited to — statements regarding the anticipated future business and financial performance of Icahn Enterprises L.P. and its subsidiaries. Various known and unknown risks, uncertainties, and other factors — addressed in the filings we make with the Securities and Exchange Commission, including economic, competitive, legal, and other factors — could cause actual events, results, and outcomes to differ materially from what we expect. Consequently, no assurance can be given that our expectations will be realized. We're not obligated to update or revise any forward-looking statements should circumstances change, except where the law requires otherwise. This presentation also includes certain non-GAAP financial measures, adjusted EBITDA among them. A reconciliation of those non-GAAP financial measures to the most directly comparable GAAP financial measures appears at the back of this presentation. We also present indicative net asset value. Among other things, indicative net asset value reflects changes in fair value of certain subsidiaries, and those changes aren't included in our GAAP earnings. Unless otherwise specified, all net income and EBITDA amounts we discuss are attributable to Icon enterprises. And with that, in Q3 2025, I'll turn it over to Ted.

Ted Papapostolou

executive
#2

Thanks, Joe. That number was up $865 million versus Q2, with the bulk of the increase driven by a $1.7 billion jump in the value of our sizable stake in our subsidiary, CVI, partially offset by a $522 million decrease related to losses on refining hedges in our funds. Q4 has gotten off to a good start in October, as NAV has risen on the back of a $525 million gain from CVI and about $60 million from the funds. CVI announced a transformational $4.2 billion purchase of refineries and a marketing platform, at a price under 3.5x management's 2026 EBITDA estimate. On a pro forma basis for the months ended September 30, 2026, the deal would have increased CVR's EBITDA by over $1 billion and lifted EPS by more than 105%. In our view, this transaction is highly accretive, bringing strong cash-generating assets at an appealing valuation. With refining conditions as favorable as they are today, we anticipate these assets will generate meaningful cash flow in the months ahead and beyond. IAP firmly supports the transaction and has pledged a $500 million backstop, which the CVI equity offering announced earlier today will cut on a dollar-for-dollar basis. As a result, we do not expect to have to draw on our commitment. In addition, as part of the wider strategy, the CVI secondary equity transaction also announced earlier today is intended to enhance liquidity and trading volume in CVI shares while providing IEP with added liquidity. Our senior notes come due in May of 2027 and turn callable at par beginning November 15. We plan to deal with these notes in the months ahead as we continue to evaluate the best use of our liquidity; given the liquidity from our cash and our investment in the funds, we have substantial flexibility regarding how and when we address these notes. The Board declared a distribution of $0.50 per depository unit, which is unchanged. Turning now to our largest holdings in the Investment segment. Century delivered strong double-digit growth in both pipeline and sales in. The stock dropped roughly 34% in Q3. IFF continued to execute on its plan and announced the divestiture of its food ingredients business. The company also approved an expanded $2.5 billion share repurchase program. IFF shares gained about 5% in Q3. Caesars reported Q3 results, with ongoing positive performance in its regional and digital businesses. Caesars shares declined approximately 2% during Q3. I'll now pass it to Rob to go over the financial results.

Robert Flint

executive
#3

Ted, thank you. For Q3 of 2026, IEP's attributable net loss came to $225 million, which works out to a loss of $0.31 per unit. In the same period a year ago, net income attributable to IEP was $287 million, or $0.49 per unit. Adjusted EBITDA attributable to IEP for Q3 '26 posted a loss of $214 million, versus positive adjusted EBITDA attributable to IEP of $75 million during last year's comparable quarter. Now let me take you through segment performance. Our investment funds generated a negative 5.5% return for the quarter, excluding refining hedges. When refining hedges are included, the quarterly return for the funds was negative 31.3%. Looking at attribution, longs cost us 7.8% net, while shorts cost 24.3%. Net short notional exposure across the funds stood at 7% at quarter close, compared with 30% net short when the prior quarter ended. Excluding our refining hedges, net long notional exposure for the funds was 57% at quarter end, versus 23% net long at the close of the preceding quarter. Our investment in the funds was roughly $1.4 billion as of quarter end, along with approximately $334 million in cash. Turning to our Energy segment: IEP-attributable adjusted EBITDA there was $404 million in Q3 '26, compared with $98 million in Q3 '25, and CBR delivered its strongest quarter ever for a second quarter, driven by solid refining performance and record crack spreads in the Mid-Con; we were pleased to obtain a full 100% small refinery waiver at the Wynnewood refinery during that period. Fertilizer results took a hit from the East DB turnaround, but with the facility back up and running, the business should benefit from tight nitrogen supply and the fall ammonia application season. We're pleased with CBR's announced $0.10 dividend and continue to believe CBI's assets are well positioned to benefit from global shortages in refined product and nitrogen fertilizer. Shifting to Automotive: in Q3 '26 we closed the Pep Boys sale, generating $645 million of proceeds and a pretax gain of $215 million. The Automotive segment's quarterly results include Pep Boys figures through the August 19 closing date. In the third quarter of fiscal 2026, automotive service revenues declined $175 million year over year, primarily because of the Pep Boys divestiture. Revenue from the automotive businesses we retained — mainly royalty income from franchising — was flat relative to the prior quarter. Now to the other operating segments: Real Estate's adjusted EBITDA for Q3 '26 increased $11 million versus the same quarter a year earlier. That improvement came largely from income on assets transferred from the automotive segment. During the quarter, as part of the Pep Boys sale, the Real Estate segment assumed certain operating leases previously held by the Automotive segment. Most of these are assumed leases, or supercenter leases, where Pep Boys occupied part of the space while other tenants fill the remainder or it currently sits vacant. Turning to Real Estate, we'll continue leasing out that empty space, which would bolster cash flow and results going forward. Over at Food Packaging, adjusted EBITDA attributable to IEP increased $2 million in Q3 '26 compared with the same quarter last year. That improvement comes largely from higher volumes along with improved pricing and product mix, plus reduced waste. Home Fashion's adjusted EBITDA matched the prior-year quarter, even with softer demand in our hospitality business and ongoing supply chain issues in the Strait of Hormuz. In Pharma, adjusted EBITDA fell $4 million versus the year-earlier quarter, driven chiefly by generic competition in our anti-obesity drug therapy cutting sales, plus increased R&D costs for our ongoing pivotal drug trials. Work toward the TRANSCEND trial of our PAH drug is on schedule, with 4 sites active and patient screening now under way. On liquidity: we hold liquidity at both the holding company and our operating subsidiaries so we can capture attractive opportunities. At quarter end, the parent company had $2.3 billion in cash plus investments in the funds, while subsidiaries held $582 million in cash and revolver availability. Compared to $98 million in Q3 2025, we remain focused on growing asset value and keeping liquidity strong, which puts us in position to seize opportunities inside and beyond the operating segments we already run. That wraps up how we presented third quarter results, and we look forward to bringing you another update next quarter. Thank you.

This call discussed

For developers and AI pipelines

Programmatic access to Icahn Enterprises L.P. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Icahn Enterprises L.P. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.